LG Chem

Company Snapshot

Founded: 1947
Entity Type: Public
Employees: 19250
Region: China
Revenue: $42,598 Millions
Revenue Year: 2023
Segment: Petrochemicals
Headquarter: Seoul, South Korea
Key Geographics: China, Europe, Korea, Asia, Americas
Corporate Address: LG Twin Towers,128, Yeoui-daero, Yeongdeungpo-gu, Seoul 150-721, Republic of Korea Tel. +82-02-3777-1114 www.lgchem.com

Company Overview

LG Chem Ltd. is a global chemicals company that is headquartered in Seoul, South Korea. In 2023, the company registered a total of 49,976 patents—17,876 in Korea, 32,100 worldwide. The company operates through five major segments, namely, LG Energy Solution, Petro-chemicals, Advanced Materials, Life Sciences, and Common and Others. The company produces and markets its thermoplastics elastomers for automotive parts and electric and electronic components; and it manufactures heat-resistant, chemical-resistant and weather-resistant elastomers in the global market.

LG Chem In Reports

Global CO2-Based Plastics Market

According to BCC Research detailed report on CO2 Based Plastics Market data was verified by industry experts and confirmed the global and regional demand for CO2-based plastics for the year 2024.

Global Market for Polymers Used in Electric Vehicles

BCC Research Report: Dive into electric vehicle polymers market considering 2023 as the base year, and the market forecast will be provided from 2024 to 2029.

Global Markets and Technologies for Bioplastics

BCC Research Report: Dive into bioplastics market report includes a detailed analysis of bioplastics in terms of raw material, product type, application, and end-use industry.

Applications/End User Industries

  • Petrochemicals
  • Advanced Materials
  • Automotive
  • Energy Storage
  • Healthcare
  • Engineering Plastics
  • Batteries
  • Pharmaceuticals
  • Lithium-Ion Batteries
  • Electric Vehicles
  • Energy Storage Systems
  • Specialty Polymers
  • Synthetic Resins
  • Ethylene
  • Propylene
  • Synthetic Fibers
  • Chemical Derivatives
  • Biopharmaceuticals
AI: Your Say